GARS1 Gene Neuronopathy distal hereditary motor type 5 Genetic Test
Test Details
GARS1 gene neuronopathy, also known as distal hereditary motor neuropathy type 5 (dHMN-V), is a rare genetic disorder that affects the peripheral nerves, specifically the motor neurons. It is caused by mutations in the GARS1 gene, which encodes an enzyme called glycyl-tRNA synthetase.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of GARS1 gene neuronopathy, NGS genetic testing can be used to identify mutations in the GARS1 gene that are associated with the condition.
NGS genetic testing for GARS1 gene neuronopathy involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the GARS1 gene and potentially other relevant genes. The sequencing data is then analyzed to identify any mutations or variants that may be causing the disorder.
This type of genetic testing can help confirm a diagnosis of GARS1 gene neuronopathy in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families with a known GARS1 gene mutation.
It is important to note that genetic testing for GARS1 gene neuronopathy may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Genetic counseling is typically recommended both before and after genetic testing to discuss the potential implications of the results and to provide support and guidance to individuals and families.
Test Name: GARS1 Gene Neuronopathy distal hereditary motor type 5 Genetic Test
Components
- Price: 4400.0 AED
Sample Condition
- Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
- 3 to 4 Weeks
Method
- NGS Technology
Test Type
- Neurological Disorders
Doctor
- Neurologist
Test Department
- Genetics
Pre Test Information
- Clinical History of Patient who is going for GARS1 Gene Neuronopathy distal hereditary motor type 5 NGS Genetic DNA Test
- A Genetic Counselling session to draw a pedigree chart of family members affected with GARS1 Gene Neuronopathy distal hereditary motor type 5
Test Name | GARS1 Gene Neuronopathy distal hereditary motor type 5 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GARS1 Gene Neuronopathy distal hereditary motor type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GARS1 Gene Neuronopathy distal hereditary motor type 5 |
Test Details |
GARS1 gene neuronopathy, also known as distal hereditary motor neuropathy type 5 (dHMN-V), is a rare genetic disorder that affects the peripheral nerves, specifically the motor neurons. It is caused by mutations in the GARS1 gene, which encodes an enzyme called glycyl-tRNA synthetase. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of GARS1 gene neuronopathy, NGS genetic testing can be used to identify mutations in the GARS1 gene that are associated with the condition. NGS genetic testing for GARS1 gene neuronopathy involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the GARS1 gene and potentially other relevant genes. The sequencing data is then analyzed to identify any mutations or variants that may be causing the disorder. This type of genetic testing can help confirm a diagnosis of GARS1 gene neuronopathy in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families with a known GARS1 gene mutation. It is important to note that genetic testing for GARS1 gene neuronopathy may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Genetic counseling is typically recommended both before and after genetic testing to discuss the potential implications of the results and to provide support and guidance to individuals and families. |